Primary immunodeficiency in the neonate: Early diagnosis and management

Kelly Walkovich1, James A Connelly2

  • 1Department of Pediatrics and Communicable Diseases, University of Michigan Medical Center, Ann Arbor, MI, USA.

Insights

Diagnosing primary immunodeficiencies (PIDs) in newborns is difficult due to immune system immaturity and the wide variety of PIDs. This review covers common neonatal PIDs, diagnosis, and care.

Area of Science:

  • Immunology
  • Neonatal Medicine
  • Genetics

Background:

  • Primary immunodeficiencies (PIDs) often present in newborns, posing diagnostic and management challenges.
  • Neonatal immune system immaturity can mask PIDs or complicate test interpretation.
  • The expanding spectrum of PIDs, including those linked to autoinflammation and autoimmunity, adds complexity.

Purpose of the Study:

  • To review common PIDs presenting in neonates.
  • To highlight challenges in diagnosing and managing neonatal PIDs.
  • To provide guidelines for diagnosis and supportive care of neonatal PIDs.

Main Methods:

  • Literature review of primary immunodeficiencies in the neonatal period.
  • Analysis of diagnostic challenges posed by immature neonatal immune systems.
  • Synthesis of current guidelines for PID diagnosis and supportive care.

Main Results:

  • Neonatal immune system immaturity complicates PID diagnosis.
  • A broad range of PIDs, including innate and adaptive immune defects, can affect neonates.
  • Recent discoveries broaden the scope of neonatal PIDs to include autoinflammatory and autoimmune conditions.

Conclusions:

  • Optimal diagnosis and management of neonatal PIDs require awareness of immune system immaturity and PID diversity.
  • Early identification and appropriate supportive care are crucial for improving outcomes in neonates with PIDs.
  • Staying current with new PID discoveries and their implications is essential for practitioners.

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.1K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
2.8K
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
19
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
43
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
370
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
19